...Qing Zhang; Yi Dong; Zhimin Zhai; Lili Tao; Qianshan Tao Introduction: Hematopoietic stem cell transplantation (HSCT) and chimeric antigen receptor T (CAR-T) cell are effective treatments for acute lymphoblastic leukemia (ALL). Various forms of intra- and extramedullary relapses have been reported...

... into complete remission (CR). Five (71.4%) patients were able to proceed to allogenic hematopoietic stem cell transplantation (HCT). Median OS was 16.6 months, with patients who received HCT having longer median OS compared to those who were unable to proceed to HCT (49.6 months vs. 3.4 months). Interestingly...

... by the reactivation of latent John Cunningham polyomavirus. Hematological disorders associated with immunomodulatory monoclonal antibodies and hematopoietic stem cell transplantation (HSCT) are risk factors for PML. Blinatumomab is a novel antileukemic immunomodulatory agent and more effective for relapsed...

... for treatment, or immune-mediated processes. Immune-mediated neuropathies (IMN) consist of a heterogeneous spectrum of peripheral nerve disorders. Although IMN is associated with several hematological disorders, it remains a very rare complication of hematopoietic stem cell transplantation (HCT). We describe...

... stem cell transplantation Iron overload Toxicity Iron overload, whether transfusion-related or not, is a well-documented complication of patients undergoing hematopoietic stem cell transplantation (HSCT) [ 1 ]. Nontransferrin-bound iron (NTBI) has been reported after myeloablative...

...Kai Yang; Yingjian Si; Huiren Chen; Xuepeng He; JinXing Lou; Xue Bai; Junfeng Du; Zhi Guo; Peng Chen Aims: To compare the efficacy of hematopoietic stem cell transplantation (HSCT) from human leukocyte antigen (HLA)-haploidentical related donors (RD) and unrelated donors (URD) in the treatment...

... the association between RANTES (regulated upon activation, normal T cell expressed and secreted) polymorphisms and clinical outcomes in patients treated with allogeneic hematopoietic stem cell transplantation (allo-HSCT). Three RANTES gene polymorphisms, i.e. –403G/A (rs2107538), –28C/G (rs2280788) and In1.1T/C...

... is the principal cause of early mortality, and stem cell transplantation is the only cure for these patients. However, the results of conventional hematopoietic stem cell transplantation (HSCT) for patients with DC are poor because of the high incidence of transplant-related complications. We describe...

...Gustavo A.M. Faulhaber; Tania W. Furlanetto; Claudia C. Astigarraga; Humberto Luiz Moser Filho; Angela Paula Paludo; Lucia M.R. Silla New indications and conditioning regimens for hematopoietic stem cell transplantation (HSCT) have emerged in the last 10 years. Previous studies have shown...

... in 49 patients: 38 received only immunosuppressive therapy (IST), 8 patients underwent hematopoietic stem cell transplantation (HSCT) – 6 as first-line therapy and 2 after failure of IST – whilst 3 patients had a spontaneous recovery. After a median follow-up of 3.19 years, 32 patients were alive...

... [ 22, 23 ] and the fludarabine/cyclophosphamide regimen used by investigators in Bethesda [ 24 ], M.D. Anderson [ 25 ], and Genoa [ 26 ]. Allogeneic Autologous Graft-versus-lymphoma effects Graft-versus-tumor effects Hematopoietic cell transplantation Hematopoietic stem cell transplantation...

...P. Corti; S. Bonanomi; C. Vallinoto; A. Balduzzi; C. Uderzo; G. Cazzaniga; G. Gaipa; M. Dassi; P. Perseghin; A. Rovelli The treatment of immune-mediated hemolytic anemia (IHA) complicating hematopoietic stem cell transplantation (HSCT) is often unsatisfactory. We report a case of IHA which occurred...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. CD34 Hematology analyzer Hematopoietic stem cell transplantation Immature information channel Peripheral blood stem cell (PBSC) transplantation is used to restore bone marrow...